
Jehanne Souaya Sitton
Examiner (ID: 17461, Phone: (571)272-0752 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682, 1655 |
| Total Applications | 1479 |
| Issued Applications | 528 |
| Pending Applications | 307 |
| Abandoned Applications | 653 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15650399
[patent_doc_number] => 20200087729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => Compositions and Methods to Detect Kidney Fibrosis
[patent_app_type] => utility
[patent_app_number] => 16/409520
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16409520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/409520 | Compositions and Methods to Detect Kidney Fibrosis | May 9, 2019 | Abandoned |
Array
(
[id] => 19932038
[patent_doc_number] => 12305237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => CXCR3 as epigenetic marker for the identification of inflammatory immune cells, in particular CD8+ memory t cells
[patent_app_type] => utility
[patent_app_number] => 17/054268
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1528
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054268 | CXCR3 as epigenetic marker for the identification of inflammatory immune cells, in particular CD8+ memory t cells | May 9, 2019 | Issued |
Array
(
[id] => 16712327
[patent_doc_number] => 20210079474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => CIRCULAR RNAS FOR THE DIAGNOSIS AND TREATMENT OF BRAIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/050285
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050285 | CIRCULAR RNAS FOR THE DIAGNOSIS AND TREATMENT OF BRAIN DISORDERS | Apr 24, 2019 | Abandoned |
Array
(
[id] => 15557581
[patent_doc_number] => 20200063202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS OF USING GENETIC MARKERS ASSOCIATED WITH ENDOMETRIOSIS
[patent_app_type] => utility
[patent_app_number] => 16/395087
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/395087 | METHODS OF USING GENETIC MARKERS ASSOCIATED WITH ENDOMETRIOSIS | Apr 24, 2019 | Abandoned |
Array
(
[id] => 16871536
[patent_doc_number] => 20210165003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => ASSESSMENT OF THE RISK OF COMPLICATION IN A PATIENT SUSPECTED OF HAVING AN INFECTION, HAVING A SOFA SCORE LOWER THAN TWO
[patent_app_type] => utility
[patent_app_number] => 17/048131
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048131 | ASSESSMENT OF THE RISK OF COMPLICATION IN A PATIENT SUSPECTED OF HAVING AN INFECTION, HAVING A SOFA SCORE LOWER THAN TWO | Apr 14, 2019 | Abandoned |
Array
(
[id] => 15557553
[patent_doc_number] => 20200063188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => BIOMARKERS FOR INFLAMMATORY SKIN DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/369724
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16369724
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/369724 | Biomarkers for inflammatory skin disease | Mar 28, 2019 | Issued |
Array
(
[id] => 14870553
[patent_doc_number] => 20190285518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => METHODS FOR PERSONALIZED DETECTION OF THE RECURRENCE OF CANCER OR METASTASIS AND/OR EVALUATION OF TREATMENT RESPONSE
[patent_app_type] => utility
[patent_app_number] => 16/356693
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356693 | METHODS FOR PERSONALIZED DETECTION OF THE RECURRENCE OF CANCER OR METASTASIS AND/OR EVALUATION OF TREATMENT RESPONSE | Mar 17, 2019 | Abandoned |
Array
(
[id] => 17267745
[patent_doc_number] => 11193160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Method and system for automated image analysis in cancer cells
[patent_app_type] => utility
[patent_app_number] => 16/355796
[patent_app_country] => US
[patent_app_date] => 2019-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11659
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16355796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/355796 | Method and system for automated image analysis in cancer cells | Mar 16, 2019 | Issued |
Array
(
[id] => 18932558
[patent_doc_number] => 11884966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Tissue-specific methylation marker
[patent_app_type] => utility
[patent_app_number] => 16/354799
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 17759
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/354799 | Tissue-specific methylation marker | Mar 14, 2019 | Issued |
Array
(
[id] => 20386816
[patent_doc_number] => 12486535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Ectopic pregnancy kits and methods
[patent_app_type] => utility
[patent_app_number] => 16/293415
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4675
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293415 | Ectopic pregnancy kits and methods | Mar 4, 2019 | Issued |
Array
(
[id] => 14838911
[patent_doc_number] => 20190277856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHODS FOR ASSESSING RISK OF INCREASED TIME-TO-FIRST-CONCEPTION
[patent_app_type] => utility
[patent_app_number] => 16/287607
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16287607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/287607 | METHODS FOR ASSESSING RISK OF INCREASED TIME-TO-FIRST-CONCEPTION | Feb 26, 2019 | Abandoned |
Array
(
[id] => 14468571
[patent_doc_number] => 20190185928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => PROSTATE CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/284963
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284963 | PROSTATE CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | Feb 24, 2019 | Pending |
Array
(
[id] => 18871461
[patent_doc_number] => 11859250
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-02
[patent_title] => Methods for treating eosinophilic esophagitis
[patent_app_type] => utility
[patent_app_number] => 16/281750
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 10787
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281750
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281750 | Methods for treating eosinophilic esophagitis | Feb 20, 2019 | Issued |
Array
(
[id] => 14752595
[patent_doc_number] => 20190259471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHODS FOR PROSTATE CANCER DETECTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/281315
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281315 | Methods for prostate cancer detection and treatment | Feb 20, 2019 | Issued |
Array
(
[id] => 16525631
[patent_doc_number] => 20200399711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => METHOD OF PREDICTING RESPONSE TO THERAPY BY ASSESSING TUMOR GENETIC HETEROGENEITY
[patent_app_type] => utility
[patent_app_number] => 16/969172
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969172 | Method of predicting response to therapy by assessing tumor genetic heterogeneity | Feb 10, 2019 | Issued |
Array
(
[id] => 16541393
[patent_doc_number] => 20200407806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SNP MOLECULAR MARKER TIGHTLY LINKED TO WEEPING TRAIT OF MEI AND DETECTION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/975651
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975651 | SNP MOLECULAR MARKER TIGHTLY LINKED TO WEEPING TRAIT OF MEI AND DETECTION METHOD AND USE THEREOF | Jan 29, 2019 | Abandoned |
Array
(
[id] => 14625325
[patent_doc_number] => 20190226030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METHODS FOR COLON CANCER DETECTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/253697
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253697 | Methods for colon cancer detection and treatment | Jan 21, 2019 | Issued |
Array
(
[id] => 16422242
[patent_doc_number] => 20200347440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => TARGETED INTERVENTIONS DIRECTED AT REDUCING THE LEVELS OF CIRCULATING SUCCINATE IN A SUBJECT, AND KITS AND METHOD FOR DETERMINING EFFECTIVENESS OF SAID INTERVENTIONS
[patent_app_type] => utility
[patent_app_number] => 16/962867
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962867 | TARGETED INTERVENTIONS DIRECTED AT REDUCING THE LEVELS OF CIRCULATING SUCCINATE IN A SUBJECT, AND KITS AND METHOD FOR DETERMINING EFFECTIVENESS OF SAID INTERVENTIONS | Jan 16, 2019 | Pending |
Array
(
[id] => 14185879
[patent_doc_number] => 20190112644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHOD AND KIT FOR GENETIC ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 16/225356
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16225356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/225356 | METHOD AND KIT FOR GENETIC ANALYSIS | Dec 18, 2018 | Abandoned |
Array
(
[id] => 18260836
[patent_doc_number] => 11608531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Biomarkers for use in prognosis of mortality in critically ill patients
[patent_app_type] => utility
[patent_app_number] => 16/216846
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19305
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/216846 | Biomarkers for use in prognosis of mortality in critically ill patients | Dec 10, 2018 | Issued |